Given that fusion-driven PCa could be associated with significant inflammatory triggers arising from the immune-rich tumor niche, there lies the possibility that NSAID drugs, such as aspirin and other non-aspirin NSAIDs, due to their ani-inflammatory effect, could be more effective in TMPRSS2-ERG fusion-positive PCa. This evidence concerns the gene TMPRSS2 and posterior cortical atrophy.